Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: Analysis of the randomized phase 3 studies SOLO 1 and SOLO 2, AD ADOL, and CHRONOS.

Journal of the American Academy of Dermatology
Jonathan I. SilverbergAbhijit Gadkari

Abstract

Pruritus (itch) is a cardinal symptom in atopic dermatitis (AD). To evaluate the timing and effect of dupilumab on itch. Analysis of data from 1505 patients with moderate to severe AD included in 4 randomized controlled studies, treated for up to 52 weeks. Adults received dupilumab 300 mg every 2 weeks or placebo monotherapy (SOLO 1: NCT02277743; SOLO 2: NCT02277769), with concomitant topical corticosteroids (CHRONOS: NCT02260986); adolescents (≥12 to <18 y) were treated with dupilumab monotherapy every 2 weeks (200 mg for baseline weight of <60 kg; 300 mg for baseline weight of ≥60 kg) or placebo (AD ADOL: NCT03054428). Dupilumab showed significant rapid improvements from baseline in daily Peak Pruritus Numerical Rating Scale scores versus placebo, by day 2 in adults and day 5 in adolescents. At treatment end, dupilumab vs placebo/control had greater least-squares mean percent change from baseline in the weekly average of Peak Pruritus Numerical Rating Scale scores: SOLO -47.5% vs -20.5%; AD-ADOL -47.9% vs -19.0%; CHRONOS -57.3% vs -30.9% (P < .0001 for all). Short duration of monotherapy trials (16 weeks). Across 4 randomized trials, dupilumab treatment showed rapid and sustained improvements in the magnitude of itch, startin...Continue Reading

References

Dec 17, 2009·The Journal of Allergy and Clinical Immunology·Joseph A OdhiamboUNKNOWN ISAAC Phase Three Study Group
Oct 14, 2011·Journal of Clinical & Cellular Immunology·Eric B Brandt, Umasundari Sivaprasad
May 16, 2012·Allergy and Asthma Proceedings·Sigrid Payne DaVeiga
Oct 8, 2013·The Journal of Allergy and Clinical Immunology·Jonathan I Silverberg, Jon M Hanifin
Apr 8, 2014·Proceedings of the National Academy of Sciences of the United States of America·Andrew J MurphyGeorge D Yancopoulos
Apr 8, 2014·Proceedings of the National Academy of Sciences of the United States of America·Lynn E MacdonaldAndrew J Murphy
Jul 10, 2014·The New England Journal of Medicine·Lisa A BeckAllen R Radin
May 1, 2015·Annals of Nutrition & Metabolism·Sophie Nutten
Oct 17, 2015·Nature Reviews. Drug Discovery·Namita A GandhiGeorge D Yancopoulos
Jan 19, 2016·Journal of the American Academy of Dermatology·Eric L SimpsonVera Mastey
Oct 4, 2016·The New England Journal of Medicine·Eric L SimpsonUNKNOWN SOLO 1 and SOLO 2 Investigators
Dec 30, 2017·American Journal of Clinical Dermatology·Janelle Pavlis, Gil Yosipovitch
Jul 22, 2018·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Jonathan I SilverbergZelma C Chiesa Fuxench
Feb 23, 2019·Cellular & Molecular Immunology·Rama Krishna Gurram, Jinfang Zhu
Oct 1, 2019·Journal of the European Academy of Dermatology and Venereology : JEADV·G YosipovitchM S Fassett

❮ Previous
Next ❯

Citations

Jul 18, 2020·The Journal of Dermatology·Kazuhisa FurueMasutaka Furue
Sep 8, 2020·Immunotherapy·Kayla FourzaliGil Yosipovitch
Jun 21, 2020·Current Allergy and Asthma Reports·Rachel Shireen GolpanianGil Yosipovitch
Jul 2, 2020·American Journal of Clinical Dermatology·Radomir ReszkeJacek C Szepietowski
Mar 5, 2021·Pharmacology & Therapeutics·Xiaoliang YangKenji Kabashima
May 21, 2020·Immunity·Fang Wang, Brian S Kim
Apr 12, 2021·The Journal of Allergy and Clinical Immunology. in Practice·Jiyoung AhnEric L Simpson
May 24, 2021·The Journal of Investigative Dermatology·Takashi HashimotoGil Yosipovitch
Jun 3, 2021·American Journal of Clinical Dermatology·Sylvia A Martinez-CabrialesMichele L Ramien
May 25, 2021·Frontiers in Medicine·Franz J Legat
Jun 10, 2021·Expert Review of Clinical Immunology·Celina DubinEmma Guttman-Yassky
Mar 4, 2021·Journal of the European Academy of Dermatology and Venereology : JEADV·G CalabreseG Argenziano
Jul 27, 2021·Frontiers in Immunology·Despina MichailidouGrant C Hughes
Aug 12, 2021·Clinical, Cosmetic and Investigational Dermatology·Zoe M LipmanGil Yosipovitch
Jul 27, 2021·Journal of the European Academy of Dermatology and Venereology : JEADV·E NettisUNKNOWN STUDY GROUP
Aug 30, 2021·Dermatologic Therapy·Luca MastorinoSimone Ribero
Nov 2, 2021·Expert Review of Clinical Immunology·Giuseppe IngrasciGil Yosipovitch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.